id	sid	eid	entity	type
ajlm-2681	1	1	pillay department	ORG
ajlm-2681	1	2	university of the witwatersrand	ORG
ajlm-2681	1	3	johannesburg	GPE
ajlm-2681	1	4	south africa	GPE
ajlm-2681	1	5	sarah a. van blydenstein department	PERSON
ajlm-2681	1	6	university of the witwatersrand	ORG
ajlm-2681	1	7	johannesburg	GPE
ajlm-2681	1	8	south africa	GPE
ajlm-2681	1	9	chris hani baragwanath hospital	PERSON
ajlm-2681	1	10	johannesburg	GPE
ajlm-2681	1	11	south africa	GPE
ajlm-2681	1	12	omar school of clinical medicine	ORG
ajlm-2681	1	13	university of the witwatersrand	ORG
ajlm-2681	1	14	johannesburg	GPE
ajlm-2681	1	15	south africa	GPE
ajlm-2681	1	16	chris hani baragwanath hospital	PERSON
ajlm-2681	1	17	johannesburg	GPE
ajlm-2681	1	18	south africa	GPE
ajlm-2681	1	19	van blydenstein sa	ORG
ajlm-2681	1	20	omar s.	PERSON
ajlm-2681	1	21	covid-19	GPE
ajlm-2681	1	22	south african	NORP
ajlm-2681	2	1	afr j	PERSON
ajlm-2681	3	1	2025;14(1	CARDINAL
ajlm-2681	3	2	1	CARDINAL
ajlm-2681	3	3	covid-19	GPE
ajlm-2681	3	4	south african	NORP
ajlm-2681	3	5	pillay	ORG
ajlm-2681	3	6	sarah a. van blydenstein	PERSON
ajlm-2681	3	7	shahed omar	PERSON
ajlm-2681	3	8	05 nov. 2024	DATE
ajlm-2681	3	9	28 jan. 2025	DATE
ajlm-2681	3	10	26	CARDINAL
ajlm-2681	3	11	2025	CARDINAL
ajlm-2681	7	1	2019	DATE
ajlm-2681	7	2	covid-19	ORG
ajlm-2681	7	3	anti-xa	NORP
ajlm-2681	8	1	anti-xa	NORP
ajlm-2681	9	1	covid-19	PERSON
ajlm-2681	10	1	covid-19	PERSON
ajlm-2681	10	2	chris hani baragwanath academic hospital	PERSON
ajlm-2681	10	3	johannesburg	GPE
ajlm-2681	10	4	south africa	GPE
ajlm-2681	10	5	november 2020	DATE
ajlm-2681	10	6	january 2021	DATE
ajlm-2681	11	1	anti-xa	PERSON
ajlm-2681	11	2	three	CARDINAL
ajlm-2681	11	3	one	CARDINAL
ajlm-2681	11	4	two	CARDINAL
ajlm-2681	12	1	20 mm	QUANTITY
ajlm-2681	13	1	forty-two	CARDINAL
ajlm-2681	13	2	covid-19	PERSON
ajlm-2681	13	3	15	CARDINAL
ajlm-2681	13	4	27	CARDINAL
ajlm-2681	15	1	0.43	CARDINAL
ajlm-2681	15	2	0.014	CARDINAL
ajlm-2681	16	1	0.52	CARDINAL
ajlm-2681	16	2	0.002	CARDINAL
ajlm-2681	16	3	0.35	CARDINAL
ajlm-2681	16	4	0.049	CARDINAL
ajlm-2681	17	1	48	CARDINAL
ajlm-2681	18	1	anti-xa	PERSON
ajlm-2681	18	2	covid-19	PERSON
ajlm-2681	20	1	anti-xa	PERSON
ajlm-2681	22	1	2019	DATE
ajlm-2681	23	1	2019	DATE
ajlm-2681	23	2	covid-19	GPE
ajlm-2681	23	3	4.8%	PERCENT
ajlm-2681	23	4	12	CARDINAL
ajlm-2681	23	5	2	CARDINAL
ajlm-2681	23	6	58.0%.3	CARDINAL
ajlm-2681	23	7	150	CARDINAL
ajlm-2681	23	8	france	GPE
ajlm-2681	23	9	20.6%	PERCENT
ajlm-2681	23	10	184	CARDINAL
ajlm-2681	23	11	netherlands	GPE
ajlm-2681	23	12	33.3%	PERCENT
ajlm-2681	24	1	covid-19	DATE
ajlm-2681	25	1	covid-19	ORG
ajlm-2681	26	1	anti-xa	NORP
ajlm-2681	26	2	xa	PERSON
ajlm-2681	26	3	anti-xa	NORP
ajlm-2681	26	4	anti-xa	NORP
ajlm-2681	27	1	anti-xa	NORP
ajlm-2681	29	1	anti-xa	NORP
ajlm-2681	29	2	as high as	CARDINAL
ajlm-2681	29	3	united states dollars	ORG
ajlm-2681	29	4	approximately 500	CARDINAL
ajlm-2681	29	5	south african	NORP
ajlm-2681	30	1	1000	CARDINAL
ajlm-2681	30	2	approximately 27 usd	CARDINAL
ajlm-2681	30	3	55 usd	CARDINAL
ajlm-2681	30	4	anti-xa	PERSON
ajlm-2681	30	5	two or more hours	TIME
ajlm-2681	32	1	lmwh).12	PERSON
ajlm-2681	34	1	30 min	QUANTITY
ajlm-2681	34	2	32	CARDINAL
ajlm-2681	34	3	153	CARDINAL
ajlm-2681	34	4	841	CARDINAL
ajlm-2681	34	5	anti-xa	NORP
ajlm-2681	35	1	done.17	ORG
ajlm-2681	35	2	anti-xa	NORP
ajlm-2681	35	3	anti-xa	NORP
ajlm-2681	36	1	tci	ORG
ajlm-2681	36	2	anti-xa	PERSON
ajlm-2681	36	3	covid-19	PERSON
ajlm-2681	42	1	chris hani baragwanath academic	PERSON
ajlm-2681	42	2	covid-19	PRODUCT
ajlm-2681	42	3	between november 2020	DATE
ajlm-2681	42	4	january 2021	DATE
ajlm-2681	43	1	chris hani baragwanath academic hospital	PERSON
ajlm-2681	43	2	johannesburg	GPE
ajlm-2681	43	3	gauteng	GPE
ajlm-2681	43	4	south africa	GPE
ajlm-2681	44	1	18 years old	DATE
ajlm-2681	45	1	93%	PERCENT
ajlm-2681	45	2	25	CARDINAL
ajlm-2681	47	1	50	CARDINAL
ajlm-2681	49	1	0.5 with 80%	PERCENT
ajlm-2681	49	2	approximately 10%	PERCENT
ajlm-2681	49	3	thromboelastograms	ORG
ajlm-2681	49	4	anti-xa	PERSON
ajlm-2681	50	1	40	CARDINAL
ajlm-2681	51	1	an additional 5%	PERCENT
ajlm-2681	51	2	2	CARDINAL
ajlm-2681	51	3	42	CARDINAL
ajlm-2681	53	1	one	CARDINAL
ajlm-2681	53	2	01 november 2020 to	DATE
ajlm-2681	53	3	31 january 2021	DATE
ajlm-2681	54	1	statistica®	ORG
ajlm-2681	54	2	13.3	CARDINAL
ajlm-2681	54	3	tibco software inc.	ORG
ajlm-2681	54	4	santa clara	GPE
ajlm-2681	54	5	california	GPE
ajlm-2681	54	6	united states	GPE
ajlm-2681	55	1	01 march 2021 to 31	DATE
ajlm-2681	55	2	2021	CARDINAL
ajlm-2681	57	1	anti-xa	NORP
ajlm-2681	58	1	48	CARDINAL
ajlm-2681	58	2	3	CARDINAL
ajlm-2681	58	3	day 10	DATE
ajlm-2681	59	1	thromboelastograms	ORG
ajlm-2681	59	2	5 min	TIME
ajlm-2681	59	3	anti-xa	PERSON
ajlm-2681	59	4	5 min	QUANTITY
ajlm-2681	60	1	6s	CARDINAL
ajlm-2681	60	2	boston	GPE
ajlm-2681	60	3	massachusetts	GPE
ajlm-2681	60	4	united states	GPE
ajlm-2681	61	1	tci	ORG
ajlm-2681	63	1	anti-xa	PERSON
ajlm-2681	63	2	becton-dickinson	PERSON
ajlm-2681	63	3	oxford	NORP
ajlm-2681	63	4	uk	GPE
ajlm-2681	64	1	anti-xa	PERSON
ajlm-2681	64	2	chris	PERSON
ajlm-2681	64	3	hani baragwanath academic	PERSON
ajlm-2681	64	4	the south african national accreditation system	ORG
ajlm-2681	64	5	iso 15189	ORG
ajlm-2681	65	1	siemens healthcare diagnostics products gmbh	ORG
ajlm-2681	65	2	marburg	GPE
ajlm-2681	65	3	germany	GPE
ajlm-2681	67	1	anti-xa	PERSON
ajlm-2681	67	2	diagnostica stago pty ltd	ORG
ajlm-2681	67	3	australia	GPE
ajlm-2681	68	1	0.6 iu	QUANTITY
ajlm-2681	68	2	1.0	CARDINAL
ajlm-2681	68	3	0.2 iu	QUANTITY
ajlm-2681	68	4	0.6	CARDINAL
ajlm-2681	72	1	first	ORDINAL
ajlm-2681	72	2	2 mm	QUANTITY
ajlm-2681	73	1	5 min	TIME
ajlm-2681	73	2	10	CARDINAL
ajlm-2681	73	3	20 mm	QUANTITY
ajlm-2681	75	1	1 min	QUANTITY
ajlm-2681	75	2	2	CARDINAL
ajlm-2681	77	1	53°–72°	DATE
ajlm-2681	78	1	50 mm	QUANTITY
ajlm-2681	78	2	70 mm.20	QUANTITY
ajlm-2681	78	3	30 min	QUANTITY
ajlm-2681	78	4	30 min	TIME
ajlm-2681	78	5	ma	PERSON
ajlm-2681	79	1	0%	PERCENT
ajlm-2681	79	2	tci	ORG
ajlm-2681	79	3	1	CARDINAL
ajlm-2681	79	4	tci	ORG
ajlm-2681	79	5	−3.0	ORG
ajlm-2681	79	6	3	CARDINAL
ajlm-2681	79	7	zero	CARDINAL
ajlm-2681	80	1	19	CARDINAL
ajlm-2681	80	2	the university of the witwatersrand	ORG
ajlm-2681	80	3	inc.	ORG
ajlm-2681	80	4	statistica	ORG
ajlm-2681	80	5	13.3	CARDINAL
ajlm-2681	80	6	tibco software inc.	ORG
ajlm-2681	80	7	santa clara	GPE
ajlm-2681	80	8	california	GPE
ajlm-2681	80	9	united states).spearman’s	ORG
ajlm-2681	81	1	mann whitney u	PERSON
ajlm-2681	82	1	1	CARDINAL
ajlm-2681	82	2	anti-xa	NORP
ajlm-2681	82	3	1	CARDINAL
ajlm-2681	83	1	≤ 0.2	CARDINAL
ajlm-2681	83	2	20%	PERCENT
ajlm-2681	85	1	anti-xa	NORP
ajlm-2681	85	2	0.05	CARDINAL
ajlm-2681	85	3	1	CARDINAL
ajlm-2681	85	4	anti-xa	NORP
ajlm-2681	85	5	48	DATE
ajlm-2681	85	6	chris hani baragwanath hospital	PERSON
ajlm-2681	85	7	johannesburg	GPE
ajlm-2681	85	8	gauteng	GPE
ajlm-2681	85	9	south africa	GPE
ajlm-2681	85	10	01	DATE
ajlm-2681	85	11	november 2020 to	DATE
ajlm-2681	85	12	31 january 2021	DATE
ajlm-2681	86	1	forty-two	CARDINAL
ajlm-2681	86	2	1	CARDINAL
ajlm-2681	87	1	22	CARDINAL
ajlm-2681	87	2	(≤ 40 mg	QUANTITY
ajlm-2681	87	3	52.38%	PERCENT
ajlm-2681	87	4	20	CARDINAL
ajlm-2681	87	5	47.61%	PERCENT
ajlm-2681	87	6	2	CARDINAL
ajlm-2681	88	1	fifteen	CARDINAL
ajlm-2681	88	2	27	CARDINAL
ajlm-2681	88	3	33 years to 74 years	DATE
ajlm-2681	90	1	1	CARDINAL
ajlm-2681	90	2	between 01 november 2020	DATE
ajlm-2681	90	3	31 january 2021	DATE
ajlm-2681	90	4	chris hani baragwanath hospital	PERSON
ajlm-2681	90	5	johannesburg	GPE
ajlm-2681	90	6	gauteng	GPE
ajlm-2681	90	7	south africa	GPE
ajlm-2681	91	1	2	CARDINAL
ajlm-2681	92	1	anti-xa	PERSON
ajlm-2681	92	2	tci	ORG
ajlm-2681	92	3	0.43	CARDINAL
ajlm-2681	92	4	0.014	CARDINAL
ajlm-2681	92	5	covid-19	PERSON
ajlm-2681	92	6	2	CARDINAL
ajlm-2681	93	1	2	CARDINAL
ajlm-2681	93	2	xa	ORG
ajlm-2681	93	3	42	CARDINAL
ajlm-2681	93	4	between 01 november 2020	DATE
ajlm-2681	93	5	31 january 2021	DATE
ajlm-2681	93	6	chris hani baragwanath hospital	PERSON
ajlm-2681	93	7	johannesburg	GPE
ajlm-2681	93	8	gauteng	GPE
ajlm-2681	93	9	south africa	GPE
ajlm-2681	94	1	anti-xa	PERSON
ajlm-2681	94	2	0.52	CARDINAL
ajlm-2681	94	3	0.002	CARDINAL
ajlm-2681	94	4	3	CARDINAL
ajlm-2681	95	1	3	CARDINAL
ajlm-2681	95	2	42	CARDINAL
ajlm-2681	95	3	between 01 november 2020	DATE
ajlm-2681	95	4	31 january 2021	DATE
ajlm-2681	95	5	chris hani baragwanath hospital	PERSON
ajlm-2681	95	6	johannesburg	GPE
ajlm-2681	95	7	gauteng	GPE
ajlm-2681	95	8	south africa	GPE
ajlm-2681	97	1	0.35	CARDINAL
ajlm-2681	97	2	0.049	CARDINAL
ajlm-2681	97	3	4	CARDINAL
ajlm-2681	98	1	4	CARDINAL
ajlm-2681	98	2	xa	ORG
ajlm-2681	98	3	42	CARDINAL
ajlm-2681	98	4	between 01 november 2020 to	DATE
ajlm-2681	98	5	31 january 2021	DATE
ajlm-2681	98	6	chris hani baragwanath hospital	PERSON
ajlm-2681	98	7	johannesburg	GPE
ajlm-2681	98	8	gauteng	GPE
ajlm-2681	98	9	south africa	GPE
ajlm-2681	101	1	0.05	CARDINAL
ajlm-2681	101	2	anti-xa	NORP
ajlm-2681	101	3	30 min	TIME
ajlm-2681	101	4	2	CARDINAL
ajlm-2681	102	1	anti-xa	PERSON
ajlm-2681	102	2	48	DATE
ajlm-2681	103	1	tci	PERSON
ajlm-2681	103	2	anti-xa	NORP
ajlm-2681	103	3	tci	ORG
ajlm-2681	104	1	tci	PERSON
ajlm-2681	104	2	anti-xa	PRODUCT
ajlm-2681	104	3	tci	ORG
ajlm-2681	105	1	tci	PERSON
ajlm-2681	105	2	5.67	CARDINAL
ajlm-2681	105	3	5.14–6.27	CARDINAL
ajlm-2681	106	1	−3.0	ORG
ajlm-2681	107	1	covid-19	ORG
ajlm-2681	108	1	tekkesin et	PERSON
ajlm-2681	109	1	turkey	GPE
ajlm-2681	109	2	2015	DATE
ajlm-2681	109	3	tci	ORG
ajlm-2681	109	4	0.0	CARDINAL
ajlm-2681	111	1	0.38	CARDINAL
ajlm-2681	111	2	tci	ORG
ajlm-2681	111	3	anti-xa	NORP
ajlm-2681	111	4	24	CARDINAL
ajlm-2681	111	5	turkey	GPE
ajlm-2681	112	1	tci	ORG
ajlm-2681	112	2	anti-xa	NORP
ajlm-2681	113	1	anti-xa	PERSON
ajlm-2681	116	1	two	CARDINAL
ajlm-2681	117	1	tci	ORG
ajlm-2681	117	2	anti-xa	PERSON
ajlm-2681	117	3	48	CARDINAL
ajlm-2681	118	1	buckley et al.	PERSON
ajlm-2681	118	2	the united states	GPE
ajlm-2681	118	3	2021	DATE
ajlm-2681	118	4	covid-19	PERSON
ajlm-2681	118	5	tci	ORG
ajlm-2681	118	6	anti-xa	NORP
ajlm-2681	119	1	anti-xa	PRODUCT
ajlm-2681	120	1	52%	PERCENT
ajlm-2681	120	2	almost 60%	PERCENT
ajlm-2681	120	3	35%	PERCENT
ajlm-2681	121	1	african	NORP
ajlm-2681	121	2	less than 10%	PERCENT
ajlm-2681	122	1	5	CARDINAL
ajlm-2681	122	2	3	CARDINAL
ajlm-2681	122	3	data.22	PERSON
ajlm-2681	122	4	48	DATE
ajlm-2681	122	5	anti-xa	NORP
ajlm-2681	123	1	anti-xa	PRODUCT
ajlm-2681	124	1	tekkesin et al.	PERSON
ajlm-2681	124	2	4	CARDINAL
ajlm-2681	124	3	12	CARDINAL
ajlm-2681	126	1	london	GPE
ajlm-2681	126	2	2002	DATE
ajlm-2681	128	1	covid-19	GPE
ajlm-2681	129	1	klein	PERSON
ajlm-2681	129	2	united states	GPE
ajlm-2681	129	3	2000	DATE
ajlm-2681	129	4	anti-xa	NORP
ajlm-2681	129	5	24	CARDINAL
ajlm-2681	131	1	australia	GPE
ajlm-2681	131	2	2011	DATE
ajlm-2681	131	3	50	CARDINAL
ajlm-2681	131	4	1 mg/kg	QUANTITY
ajlm-2681	131	5	anti-xa	PERSON
ajlm-2681	131	6	48	CARDINAL
ajlm-2681	132	1	4.17	CARDINAL
ajlm-2681	132	2	± 0.5	CARDINAL
ajlm-2681	132	3	anti-xa	NORP
ajlm-2681	133	1	100 mg	QUANTITY
ajlm-2681	133	2	more than 100 kg	QUANTITY
ajlm-2681	134	1	buckley et al.	PERSON
ajlm-2681	134	2	anti-xa	NORP
ajlm-2681	134	3	daily	DATE
ajlm-2681	135	1	artang et al	PERSON
ajlm-2681	136	1	denmark	GPE
ajlm-2681	136	2	2009	DATE
ajlm-2681	136	3	seven	CARDINAL
ajlm-2681	136	4	120	CARDINAL
ajlm-2681	136	5	anti-xa	NORP
ajlm-2681	136	6	2	CARDINAL
ajlm-2681	136	7	4	DATE
ajlm-2681	136	8	5	DATE
ajlm-2681	136	9	24	CARDINAL
ajlm-2681	137	1	24	CARDINAL
ajlm-2681	137	2	0.82	CARDINAL
ajlm-2681	139	1	seven	CARDINAL
ajlm-2681	139	2	covid-19	ORG
ajlm-2681	140	1	0.35	CARDINAL
ajlm-2681	140	2	buckley et al	PERSON
ajlm-2681	140	3	0.08	CARDINAL
ajlm-2681	141	1	3	CARDINAL
ajlm-2681	141	2	anti-xa	NORP
ajlm-2681	142	1	mentioned.22	PRODUCT
ajlm-2681	142	2	buckley et al.22	PERSON
ajlm-2681	142	3	as much as 80%	PERCENT
ajlm-2681	142	4	ma	PERSON
ajlm-2681	142	5	activity,26	ORG
ajlm-2681	144	1	chandel et al.	PERSON
ajlm-2681	145	1	24	CARDINAL
ajlm-2681	145	2	covid-19 pneumonia.27	PERSON
ajlm-2681	146	1	anti-xa	NORP
ajlm-2681	146	2	parameters.27	PERSON
ajlm-2681	147	1	lloyd-donald et al	ORG
ajlm-2681	148	1	australia	GPE
ajlm-2681	148	2	2020	DATE
ajlm-2681	150	1	firstly	ORDINAL
ajlm-2681	151	1	secondly	ORDINAL
ajlm-2681	151	2	two	CARDINAL
ajlm-2681	154	1	second	ORDINAL
ajlm-2681	155	1	tci	ORG
ajlm-2681	155	2	anti-xa	PERSON
ajlm-2681	156	1	tci	ORG
ajlm-2681	156	2	anti-xa	NORP
ajlm-2681	158	1	tci	PERSON
ajlm-2681	158	2	anti-xa	NORP
ajlm-2681	159	1	anti-xa	PERSON
ajlm-2681	159	2	30 min	TIME
ajlm-2681	160	1	anti-xa	NORP
ajlm-2681	160	2	anti-xa	NORP
ajlm-2681	163	1	b.p	PERSON
ajlm-2681	163	2	covid-19	GPE
ajlm-2681	163	3	south african	NORP
ajlm-2681	163	4	south africa	GPE
ajlm-2681	163	5	20 december 2024	DATE
ajlm-2681	163	6	dr s.a. van blydenstein	PERSON
ajlm-2681	163	7	s. omar	PERSON
ajlm-2681	165	1	teg	ORG
ajlm-2681	165	2	6s	CARDINAL
ajlm-2681	166	1	qiagen	ORG
ajlm-2681	167	1	b.p.	GPE
ajlm-2681	167	2	s.a.v.b.	GPE
ajlm-2681	167	3	s.o.	GPE
ajlm-2681	168	1	s.o.	GPE
ajlm-2681	168	2	b.p	PERSON
ajlm-2681	169	1	b.p	PERSON
ajlm-2681	169	2	s.a.v.b	DATE
ajlm-2681	170	1	b.p.	PERSON
ajlm-2681	170	2	s.a.v.b.	GPE
ajlm-2681	170	3	s.o.	GPE
ajlm-2681	171	1	6s	CARDINAL
ajlm-2681	172	1	b.p.	PERSON
ajlm-2681	177	1	covid-19	ORG
ajlm-2681	178	1	2021	CARDINAL
ajlm-2681	179	1	2021	CARDINAL
ajlm-2681	179	2	june 27	DATE
ajlm-2681	180	1	covid-19	GPE
ajlm-2681	181	1	2021;160(4):1471–1480	CARDINAL
ajlm-2681	182	1	https://doi.org/10.1016/j.chest.2021.06.016	ORG
ajlm-2681	182	2	leone m	PERSON
ajlm-2681	183	1	disease-2019	DATE
ajlm-2681	183	2	covid-19	ORG
ajlm-2681	185	1	2020;10(1):124	PERSON
ajlm-2681	186	1	wu x	PERSON
ajlm-2681	186	2	xiang m	PERSON
ajlm-2681	186	3	liu l	PERSON
ajlm-2681	186	4	novakovic va	GPE
ajlm-2681	186	5	shi j. pathophysiological mechanisms	PERSON
ajlm-2681	186	6	covid-19	PRODUCT
ajlm-2681	188	1	https://doi.org/10.3389/fimmu.2022.992384	ORG
ajlm-2681	188	2	ac	ORG
ajlm-2681	188	3	resnick	PERSON
ajlm-2681	188	4	bradbury	GPE
ajlm-2681	189	1	covid-19	DATE
ajlm-2681	190	1	2022	CARDINAL
ajlm-2681	191	1	dutt t	PERSON
ajlm-2681	191	2	simcox	GPE
ajlm-2681	191	3	downey c	ORG
ajlm-2681	191	4	covid-19	DATE
ajlm-2681	192	1	j respir crit	PERSON
ajlm-2681	193	1	2020;202(3):455–457	ORG
ajlm-2681	193	2	https://doi.org/10.1164/rccm.202005-1654le middeldorp s	ORG
ajlm-2681	193	3	coppens m	PERSON
ajlm-2681	194	1	covid-19	PERSON
ajlm-2681	195	1	j thromb haemost	PERSON
ajlm-2681	196	1	2020;18(8):1995–2002	CARDINAL
ajlm-2681	197	1	https://doi.org/10.1111/jth.14888 helms j	PERSON
ajlm-2681	199	1	2020;46(6):1089–1098	CARDINAL
ajlm-2681	200	1	klok fa	PERSON
ajlm-2681	200	2	kruip mjha	GPE
ajlm-2681	200	3	van der meer	PERSON
ajlm-2681	200	4	covid-19	PERSON
ajlm-2681	201	1	thromb res	PERSON
ajlm-2681	202	1	2020;191:148–150	CARDINAL
ajlm-2681	203	1	salvador e	GPE
ajlm-2681	204	1	anti-xa	PERSON
ajlm-2681	206	1	2020;196:432–434	DATE
ajlm-2681	207	1	thomas o	PERSON
ajlm-2681	207	2	lybeck e	PERSON
ajlm-2681	207	3	strandberg k	PERSON
ajlm-2681	207	4	aptt	GPE
ajlm-2681	208	1	plos one	ORG
ajlm-2681	209	1	2015;10(1):e0116835	CARDINAL
ajlm-2681	210	1	barnard s	ORG
ajlm-2681	210	2	monis g. anti-factor	PERSON
ajlm-2681	211	1	uc davis health	PERSON
ajlm-2681	212	1	uc davis health	PERSON
ajlm-2681	213	1	2017	CARDINAL
ajlm-2681	214	1	2021	CARDINAL
ajlm-2681	214	2	oct 03	DATE
ajlm-2681	215	1	sigmon df	PERSON
ajlm-2681	218	1	2021	CARDINAL
ajlm-2681	219	1	2021	CARDINAL
ajlm-2681	219	2	oct 03	DATE
ajlm-2681	220	1	jackson gnb	PERSON
ajlm-2681	220	2	ashpole kj	PERSON
ajlm-2681	220	3	yentis sm	PERSON
ajlm-2681	223	1	2009;64(2):212–215	CARDINAL
ajlm-2681	223	2	collett lw	PERSON
ajlm-2681	223	3	gluck s	PERSON
ajlm-2681	223	4	strickland rm	PERSON
ajlm-2681	223	5	reddi	GPE
ajlm-2681	224	1	2019	DATE
ajlm-2681	224	2	covid-19	ORG
ajlm-2681	225	1	aust crit	ORG
ajlm-2681	226	1	2021;34(2):155–159	CARDINAL
ajlm-2681	226	2	kazi	PERSON
ajlm-2681	226	3	deng y	PERSON
ajlm-2681	226	4	othman m. teg/rotem	PERSON
ajlm-2681	226	5	19	CARDINAL
ajlm-2681	227	1	2021	CARDINAL
ajlm-2681	228	1	2021	CARDINAL
ajlm-2681	228	2	oct 03];pb0199	DATE
ajlm-2681	229	1	vail	GPE
ajlm-2681	229	2	anti-xa	NORP
ajlm-2681	230	1	anesth analg	PERSON
ajlm-2681	231	1	2000;91(5):1091–1095	CARDINAL
ajlm-2681	232	1	https://doi.org/10.1097/00000539-200011000-00009	NORP
ajlm-2681	232	2	kaso g.	PERSON
ajlm-2681	233	1	anatol j cardiol	PERSON
ajlm-2681	234	1	2015;15(11):932–937	PERSON
ajlm-2681	235	1	https://doi.org/10.5152/akd.2014.5723 harris pa	PERSON
ajlm-2681	235	2	taylor r	PERSON
ajlm-2681	235	3	elliott v	PERSON
ajlm-2681	235	4	fernandez m	PERSON
ajlm-2681	238	1	2019	CARDINAL
ajlm-2681	239	1	whitton tp	PERSON
ajlm-2681	239	2	healy wj	PERSON
ajlm-2681	241	1	adv pulm crit	ORG
ajlm-2681	242	1	2023;18:29768675231208426	CARDINAL
ajlm-2681	242	2	sigmon df	PERSON
ajlm-2681	244	1	2025	CARDINAL
ajlm-2681	244	2	2025	CARDINAL
ajlm-2681	244	3	jan 21	DATE
ajlm-2681	245	1	buckley ms	PERSON
ajlm-2681	245	2	benanti ge	PERSON
ajlm-2681	245	3	gilbert b	PERSON
ajlm-2681	245	4	dzierba al	PERSON
ajlm-2681	245	5	maclaren r. correlation	PERSON
ajlm-2681	245	6	anti-xa	NORP
ajlm-2681	245	7	covid-19	PRODUCT
ajlm-2681	247	1	2023;43(8):795–803	CARDINAL
ajlm-2681	248	1	widman j	PERSON
ajlm-2681	248	2	menyes p	GPE
ajlm-2681	248	3	levin k	PERSON
ajlm-2681	249	1	clin sci	PERSON
ajlm-2681	249	2	lond	PERSON
ajlm-2681	250	1	2002;102(3):279–286	CARDINAL
ajlm-2681	251	1	sosnowski k	PERSON
ajlm-2681	251	2	jones m	PERSON
ajlm-2681	253	1	2012;23(4):304–310	CARDINAL
ajlm-2681	254	1	artang	GPE
ajlm-2681	254	2	frandsen nj	GPE
ajlm-2681	254	3	nielsen jd	PERSON
ajlm-2681	255	1	thromb j. 2009;7:14	PERSON
ajlm-2681	256	1	harr jn	PERSON
ajlm-2681	256	2	moore ee	PERSON
ajlm-2681	256	3	chin tl	PERSON
ajlm-2681	259	1	762–765	CARDINAL
ajlm-2681	260	1	https://doi.org/10.1097/ta.0b013e3182826d7e chandel	ORG
ajlm-2681	260	2	khangoora	PERSON
ajlm-2681	260	3	covid-19	GPE
ajlm-2681	262	1	2021;36(6):689–695	CARDINAL
ajlm-2681	263	1	lloyd-donald	PERSON
ajlm-2681	264	1	clin appl thromb	ORG
ajlm-2681	265	1	2020;26:107602962092591	CARDINAL